T67A (p.Thr67Ala) variant of AGT (Angiotensinogen)
T67A (p.Thr67Ala) in AGT (Angiotensinogen) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.39 / 1. The record also includes population frequency data and structural context.
T67A (p.Thr67Ala) variant details
- p.Thr67Ala
- rs763626003
- NCI-TCGA Cosmic COSV6418
- ExAC rs763626003
- gnomAD rs763626003
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.389
- AlphaMissense 0.09
- MetaLR 0.32
- MetaSVM -0.68
- PolyPhen-2 0.06
- SIFT 0.10
- MutPred 0.30
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available
- Structural context available